As previously discussed, MMP-9 is aberrantly regulated in both DMD patients and mdx mice and likely involved in the cross-talk between inflammation (NF-κB activation augments MMP-9 expression) and fibrosis (MMP-9 cleaves latent TGF-β1). Here, MMP9 is linked to Duchenne muscular dystrophy.